Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2006;92:1360
Copyright © 2006 BMJ Publishing Group Ltd & British Cardiovascular Society

JournalScan

Iqbal Malik, Editor

The first 150 words of the full text of this article appear below.


ISCHAEMIC HEART DISEASE

N-acetylcysteine and nephropathy {blacktriangleright}

Patients with acute myocardial infarction undergoing primary angioplasty are at high risk for contrast medium induced nephropathy because of haemodynamic instability and the need for a high volume of contrast medium. N-acetylcysteine (NAC) has been tested in elective percutaneous coronary intervention and may prevent nephropathy. A total of 354 consecutive patients undergoing primary angioplasty were randomised to one of three groups: 116 patients were assigned to a standard dose of NAC (a 600 mg intravenous bolus before primary angioplasty and 600 mg orally twice daily for the 48 hours after angioplasty), 119 patients to a double dose of NAC (a 1200 mg intravenous bolus and 1200 mg orally twice daily for the 48 hours after intervention), and 119 patients to placebo. The serum creatinine concentration increased 25% or more from baseline after primary angioplasty in 39 of the control patients (33%), 17 of the patients receiving standard dose NAC (15%), . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.